Related Experiment Video
Updated: Apr 27, 2026
12:19
Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
Published on: June 7, 2024
2.1K
Immunomodulation in cancer
Joost P J J Hegmans1, Joachim G J V Aerts1
1Erasmus MC Cancer Institute, Department of Pulmonary Medicine, Ee 2253a, Dr. Molewaterplein 50, 3045 PE Rotterdam, The Netherlands.
Current Opinion in Pharmacology
|July 11, 2014
Summary
To effectively treat cancer with immunotherapy, understand the tumor and its microenvironment. Personalized treatment strategies adapting to cancer
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- Cancer immunotherapy harnesses the immune system to fight tumors.
- Tumor microenvironment comprises cancer cells, stromal cells, endothelial cells, and immune cells.
- Immune cells play dual roles, aiding or hindering treatment, necessitating strategic consideration.
Purpose of the Study:
- To emphasize the strategic "chess-playing" approach required for successful cancer immunotherapy.
- To highlight the importance of understanding the tumor and its evolving microenvironment.
- To advocate for personalized treatment strategies based on biomarkers.
Main Methods:
- Conceptual framework using a chess analogy to describe cancer treatment.
- Analysis of the roles of various cellular components within the tumor microenvironment.
- Emphasis on adaptive strategies in cancer immunotherapy.
Main Results:
- Identified key cellular players in the tumor microenvironment and their functions.
- Illustrated the dynamic and complex nature of cancer as an "opponent."
- Stressed the necessity of a personalized and adaptive therapeutic approach.
Conclusions:
- Successful cancer immunotherapy requires a deep understanding of the tumor and its microenvironment.
- Personalized treatment selection and adaptive strategies are crucial for controlling cancer growth.
- A "chess-playing" mindset is essential for advancing cancer immunotherapy.
Related Concept Videos
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
01:30Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
02:57Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
02:49Cancer Therapies
8.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K
02:17The Tumor Microenvironment
6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
01:27Cytotoxic T Cells-mediated Immune Response
7.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K